Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H27NO2S |
| Molecular Weight | 321.477 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)C1=CC(CC2SCNC2=O)=CC(=C1O)C(C)(C)C
InChI
InChIKey=ILMMRHUILQOQGP-UHFFFAOYSA-N
InChI=1S/C18H27NO2S/c1-17(2,3)12-7-11(9-14-16(21)19-10-22-14)8-13(15(12)20)18(4,5)6/h7-8,14,20H,9-10H2,1-6H3,(H,19,21)
| Molecular Formula | C18H27NO2S |
| Molecular Weight | 321.477 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Discovery of a solid solution of enantiomers in a racemate-forming system by seeding. | 2006-09-13 |
|
| Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes. | 1999 |
|
| In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofelone. | 1997-12 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://adisinsight.springer.com/drugs/800006634
Unknown
Route of Administration:
Rectal
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:32:01 GMT 2025
by
admin
on
Mon Mar 31 18:32:01 GMT 2025
|
| Record UNII |
VH2I1JN8Q1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C574
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
VH2I1JN8Q1
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
136433-51-7
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
7369
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
SUB10850MIG
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
68745
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
107902-67-0
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
SUPERSEDED | |||
|
GG-34
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL132991
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
100000082453
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
C76695
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY | |||
|
C109841
Created by
admin on Mon Mar 31 18:32:01 GMT 2025 , Edited by admin on Mon Mar 31 18:32:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|